000			01242 a2200313 4500
005			20250513191808.0
264		0	_c19990914
008			199909s 0 0 eng d
022			_a1524-4539
024	7		_a10.1161/01.cir.100.9.999 _2doi
040			_aNLM _beng _cNLM
100	1		_aMann, D L
245	0	0	_aMechanisms and models in heart failure: A combinatorial approach. _h[electronic resource]
260			_bCirculation _cAug 1999
300			_a999-1008 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAdrenergic beta-Antagonists _xtherapeutic use
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aCardiotonic Agents _xtherapeutic use
650	0	4	_aDisease Progression
650	0	4	_aDiuretics _xtherapeutic use
650	0	4	_aHeart Failure _xcomplications
650	0	4	_aHumans
650	0	4	_aHypertrophy, Left Ventricular _xcomplications
650	0	4	_aStroke Volume
650	0	4	_aVasodilator Agents _xtherapeutic use
773	0		_tCirculation _gvol. 100 _gno. 9 _gp. 999-1008
856	4	0	_uhttps://doi.org/10.1161/01.cir.100.9.999 _zAvailable from publisher's website
999			_c10426055 _d10426055